Literature DB >> 19342453

Characterization of intracellular signaling mediated by human somatostatin receptor 5: role of the DRY motif and the third intracellular loop.

Erika Peverelli1, Andrea G Lania, Giovanna Mantovani, Paolo Beck-Peccoz, Anna Spada.   

Abstract

Somatostatin (SST) exerts inhibitory effects on hormone secretion and cell proliferation by interacting with five different receptors (SST1-SST5) linked to multiple cellular effectors. The receptor structural domains involved in these effects have been only partially elucidated. The aim of the study was to investigate the molecular determinants mediating the interaction of the human SST5 with intracellular signaling in the pituitary cell line GH3, focusing on the BBXXB domain in the third intracellular loop and the DRY motif in the second intracellular loop. We analyzed the effects of the SST5 agonist BIM23206 on cAMP accumulation, intracellular calcium, GH secretion, cell proliferation, and ERK1/2 phosphorylation in cells expressing either wild-type SST5 or mutant receptors, in particular the naturally occurring mutant R240W in the BBXXB domain and the D136A and R137A mutants in the DRY motif. We found that residues D136 and R137 were critical for SST5 signaling because their substitutions abolished all the intracellular responses. Conversely, third intracellular loop mutations resulted in receptor that inhibited intracellular cAMP levels similar to the wild-type (50 +/- 9 vs. 53 +/- 12% inhibition) but failed to mediate the other responses elicited by wild-type SST5, i.e. reduction of intracellular calcium levels as well as inhibition of ERK1/2. These events resulted in an absent inhibition of GH release and an impaired reduction of cell proliferation (38 +/- 7 vs. 76 +/- 6% inhibition in wild type, P < 0.05). These data indicate that different regions of SST5 are required for the activation of different signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342453      PMCID: PMC2703549          DOI: 10.1210/en.2008-1785

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  48 in total

1.  C-terminal region of human somatostatin receptor 5 is required for induction of Rb and G1 cell cycle arrest.

Authors:  K Sharma; Y C Patel; C B Srikant
Journal:  Mol Endocrinol       Date:  1999-01

2.  The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling.

Authors:  F Lopez; J P Estève; L Buscail; N Delesque; N Saint-Laurent; M Théveniau; C Nahmias; N Vaysse; C Susini
Journal:  J Biol Chem       Date:  1997-09-26       Impact factor: 5.157

3.  Structural determinants in the second intracellular loop of the human follicle-stimulating hormone receptor are involved in G(s) protein activation.

Authors:  Carlos Timossi; David Maldonado; Andrea Vizcaíno; Barbara Lindau-Shepard; P Michael Conn; Alfredo Ulloa-Aguirre
Journal:  Mol Cell Endocrinol       Date:  2002-03-28       Impact factor: 4.102

4.  Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors.

Authors:  I Shimon; X Yan; J E Taylor; M H Weiss; M D Culler; S Melmed
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

5.  Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly.

Authors:  M Filopanti; C Ronchi; E Ballarè; S Bondioni; A G Lania; M Losa; S Gelmini; A Peri; C Orlando; P Beck-Peccoz; A Spada
Journal:  J Clin Endocrinol Metab       Date:  2005-05-24       Impact factor: 5.958

6.  Modulation of GDP release from transducin by the conserved Glu134-Arg135 sequence in rhodopsin.

Authors:  S Acharya; S S Karnik
Journal:  J Biol Chem       Date:  1996-10-11       Impact factor: 5.157

7.  Role of the third intracellular loop for the activation of gonadotropin receptors.

Authors:  A Schulz; T Schöneberg; R Paschke; G Schultz; T Gudermann
Journal:  Mol Endocrinol       Date:  1999-02

8.  Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro.

Authors:  G Weckbecker; R Liu; L Tolcsvai; C Bruns
Journal:  Cancer Res       Date:  1992-09-15       Impact factor: 12.701

9.  Identification of regions in the human angiotensin II receptor type 1 responsible for Gi and Gq coupling by mutagenesis study.

Authors:  T Shibata; C Suzuki; J Ohnishi; K Murakami; H Miyazaki
Journal:  Biochem Biophys Res Commun       Date:  1996-01-05       Impact factor: 3.575

10.  The function of a highly-conserved arginine residue in activation of the muscarinic M1 receptor.

Authors:  P G Jones; C A Curtis; E C Hulme
Journal:  Eur J Pharmacol       Date:  1995-02-15       Impact factor: 4.432

View more
  9 in total

1.  Novel GαS-protein signaling associated with membrane-tethered amyloid precursor protein intracellular domain.

Authors:  Carole Deyts; Kulandaivelu S Vetrivel; Shibandri Das; Yumiko M Shepherd; Denis J Dupré; Gopal Thinakaran; Angèle T Parent
Journal:  J Neurosci       Date:  2012-02-01       Impact factor: 6.167

2.  Peptides corresponding to intracellular regions of somatostatin receptors with agonist and antagonist activity.

Authors:  E A Shpakova; A O Shpakov
Journal:  Dokl Biochem Biophys       Date:  2011-05-18       Impact factor: 0.788

Review 3.  International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.

Authors:  Thomas Günther; Giovanni Tulipano; Pascal Dournaud; Corinne Bousquet; Zsolt Csaba; Hans-Jürgen Kreienkamp; Amelie Lupp; Márta Korbonits; Justo P Castaño; Hans-Jürgen Wester; Michael Culler; Shlomo Melmed; Stefan Schulz
Journal:  Pharmacol Rev       Date:  2018-10       Impact factor: 25.468

4.  Identification of human somatostatin receptor 2 domains involved in internalization and signaling in QGP-1 pancreatic neuroendocrine tumor cell line.

Authors:  Valeria Cambiaghi; Eleonora Vitali; Diego Morone; Erika Peverelli; Anna Spada; Giovanna Mantovani; Andrea Gerardo Lania
Journal:  Endocrine       Date:  2016-07-12       Impact factor: 3.633

5.  Effects of octreotide on autophagy markers and cell viability markers related to metabolic activity in rat pituitary tumor cells.

Authors:  Giovanni Tulipano; Andrea Giustina
Journal:  Pituitary       Date:  2020-06       Impact factor: 4.107

Review 6.  Drug resistance in pituitary tumours: from cell membrane to intracellular signalling.

Authors:  Erika Peverelli; Donatella Treppiedi; Federica Mangili; Rosa Catalano; Anna Spada; Giovanna Mantovani
Journal:  Nat Rev Endocrinol       Date:  2021-06-30       Impact factor: 43.330

7.  Identification and characterization of new functional truncated variants of somatostatin receptor subtype 5 in rodents.

Authors:  Jose Córdoba-Chacón; Manuel D Gahete; Mario Duran-Prado; Ana I Pozo-Salas; María M Malagón; F Gracia-Navarro; Rhonda D Kineman; Raul M Luque; Justo P Castaño
Journal:  Cell Mol Life Sci       Date:  2010-04       Impact factor: 9.261

8.  Clinical significance of filamin A in patients with acromegaly and its association with somatostatin and dopamine receptor profiles.

Authors:  Maria Caroline Alves Coelho; Marina Lipkin Vasquez; Luiz Eduardo Wildemberg; Mari C Vázquez-Borrego; Luciana Bitana; Aline Helen da Silva Camacho; Débora Silva; Liana Lumi Ogino; Nina Ventura; Rafael Sánchez-Sánchez; Leila Chimelli; Leandro Kasuki; Raul M Luque; Mônica R Gadelha
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

Review 9.  Dopamine and Somatostatin Analogues Resistance of Pituitary Tumors: Focus on Cytoskeleton Involvement.

Authors:  Erika Peverelli; Donatella Treppiedi; Elena Giardino; Eleonora Vitali; Andrea G Lania; Giovanna Mantovani
Journal:  Front Endocrinol (Lausanne)       Date:  2015-12-22       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.